Moodle at CCNM

Autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus are common, debilitating, and expensive diseases to manage. Current treatment strategies rarely achieve full remission, and the side effects of treatment can be severe. New research is uncovering that the immune system, like any other organ system in the body, has metabolic changes during the disease process. We are now understanding that immune mediated diseases can develop a metabolic signature, and therapies that modulate energy utilization within immune cells is uncovering new and exciting therapies.

This talk will cover clinical indications for ordering an Anti-nuclear Antibody test, as well as a review of optimal lab methodology. We will cover a clinical review of the following ANA positive diseases: Systemic Lupus Erythematosus, Sjogrens, Scleroderma, Dermatomyositis ,Polymyositis. While the focus is on recognizing these disorders, will also discuss conventional and integrative approaches to treating these disorders.